B+
Bull case
25%
Probability
Target price
$500.00
+17.3% vs current
UNH
UnitedHealth GroupBNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+1Most likely
B
Base case
50%
Probability
Target price
$460.00
+8.0% vs current
B-
Bear case
25%
Probability
Target price
$365.00
-14.3% vs current
AI sentiment snapshot
Latest data as of 2026-07-17
Recent news sentiment (30D)
+30.0
Positive
Company
-
Unavailable
Macro
+30.0
Positive
Pulse
-
Unavailable
Sentiment proxy
+50.6
Score
AI commentary
News tone is strongly positive after the Q2 release and guidance increase, with packet coverage reporting a roughly 10% post-print rally. The primary earnings evidence is strong, but social coverage and post-print analyst revisions are unavailable; therefore, confidence should remain below a full-conviction bullish rating and focus on whether the initial reaction holds.
RankAlpha Sentiment Codex - 2026-07-17
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-31catalystRaised FY2026 earnings outlook supports near-term reratingMedium impact
Q2 revenue was $112.0 billion and adjusted EPS was $6.38. Management raised full-year 2026 adjusted earnings guidance to $19.50-$20.00 per share, improving the near-term earnings narrative. [#SEC-8K-2026-07-16]
2026-09-30eventMedical-cost and Optum margin durability checkpointMedium impact
Q2 medical cost ratio was 86.7%, including $860 million of favorable prior-period development, while Optum delivered 160 basis points of year-over-year margin expansion. Sustaining these trends is important for validating the guidance increase; normalization of favorable development or renewed utilization pressure would weaken the thesis. [#SEC-8K-2026-07-16]
2026-12-31catalystOperating reset and balance-sheet normalizationHigh impact
The company is pursuing simplification, technology investment, leadership changes, and a lower debt-to-capital ratio. Durable execution across UnitedHealthcare and Optum could support a longer-term rerating, but the current debt-to-capital ratio remains 41.2%. [#SEC-8K-2026-04-21] [#SEC-8K-2026-07-16]
Recommendation
N/A
No formal recommendation provided.
As of 2026-07-17 • Updated nightlySource: Internal modelMethodology